6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Digital Mental Health and Telepsychiatry
The rise of technology-driven solutions is reshaping psychiatric care delivery. Digital mental health and telepsychiatry now offer unprecedented access to therapy, psychiatric evaluations, and crisis interventions across geographical and economic barriers. Mobile apps provide mood tracking, cognitive behavioral tools, and mindfulness exercises, while virtual platforms enable real-time consultations with licensed professionals. These tools not only address provider shortages but also empower patients to manage their mental health proactively. However, concerns around privacy, equity, and clinical efficacy continue to prompt regulatory and ethical discussions. The ongoing development of AI-assisted mental health bots and VR-based exposure therapies further illustrates the expanding role of digital interfaces in personalized psychiatric care.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States